Literature DB >> 19148519

'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine.

Alberto Di Martino1, Bruno Vincenzi, Luca Denaro, Simona Angela Barnaba, Rocco Papalia, Daniele Santini, Giuseppe Tonini, Vincenzo Denaro.   

Abstract

In patients with thoracolumbar spine metastasis, surgery is aimed at patient healing only when patient has a good prognosis with long life expectancy. In patients with short life expectancy a less aggressive surgical approach of posterior decompression and stabilization could improve patient care and allow for neurological recovery. Thirty-two consecutive patients affected by symptomatic thoracolumbar spine metastases with short life expectancy and good Karnofsky index (50-70) were subjected to surgery and reviewed retrospectively. After tumor embolization, surgery consisted of posterior decompression and stabilization with laminar hooks in the dorsal spine, and laminar hooks or lumbar pedicle screws. Patient's Karnofsky Index, average survival, Frankel neurological status, and pain were recorded before and after surgery, together with surgery related complications. Primary tumors were breast carcinoma (nine patients), renal cell carcinoma (three), lung carcinoma (four), GI tract carcinoma (six), prostate carcinoma (two), carcinoma of the uterus (two), melanoma (three), and malignant tumors at other different sites (three). Average survival after surgery was 23 months, with highest survival rates in renal cancer and breast carcinoma patients, and poorest survival rates in lung and dedifferentiated carcinoma. Karnofsky index improved from average 61 to 72% post-operatively. After surgery patients experienced significant overall improvement of Frankel score and decrease of referred pain. Hospitalization stay was on average 10 days. Results showed that operative treatment of symptomatic spinal metastases in patients with poor prognosis and good general health status improves or preserves neurological function, allows for adjuvant treatments to be performed and has a role in improving general health status in most patients.

Entities:  

Mesh:

Year:  2009        PMID: 19148519

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Patients with cervical metastasis and neoplastic pachymeningitis are less likely to improve neurologically after surgery.

Authors:  Vincenzo Denaro; Alberto Di Martino; Rocco Papalia; Luca Denaro
Journal:  Clin Orthop Relat Res       Date:  2011-03       Impact factor: 4.176

2.  Does the anatomical region predict blood loss or neurological deficits in embolized renal cancer spine metastases? A single-center experience with 31 patients.

Authors:  Anna Voelker; Georg Osterhoff; Stefanie Einhorn; Sebastian Ebel; Christoph-Eckhard Heyde; Philipp Pieroh
Journal:  World J Surg Oncol       Date:  2022-06-16       Impact factor: 3.253

3.  Osteolytic vs. Osteoblastic Metastatic Lesion: Computational Modeling of the Mechanical Behavior in the Human Vertebra after Screws Fixation Procedure.

Authors:  Daniele Bianchi; Cristina Falcinelli; Leonardo Molinari; Alessio Gizzi; Alberto Di Martino
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

4.  Minimally invasive option using percutaneous pedicle screw for instability of metastasis involving thoracolumbar and lumbar spine : a case series in a single center.

Authors:  Ho-Young Park; Sun-Ho Lee; Se-Jun Park; Eun-Sang Kim; Chong-Suh Lee; Whan Eoh
Journal:  J Korean Neurosurg Soc       Date:  2015-02-26

5.  Treatment of Spinal Metastases with Epidural Cord Compression through Corpectomy and Reconstruction via the Traditional Open Approach versus the Mini-Open Approach: A Multicenter Retrospective Study.

Authors:  Xi Zhou; Haomin Cui; Yu He; Guixing Qiu; Dongsheng Zhou; Yong Liu
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

6.  Analysis of orthopedic surgery of bone metastases in breast cancer patients.

Authors:  Bernd Wegener; Marcus Schlemmer; Joachim Stemmler; Volkmar Jansson; Hans Roland Dürr; Matthias F Pietschmann
Journal:  BMC Musculoskelet Disord       Date:  2012-11-27       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.